These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7721766)

  • 1. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
    Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
    J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta.
    Bateman JF; Lamande SR; Dahl HH; Chan D; Mascara T; Cole WG
    J Biol Chem; 1989 Jul; 264(19):10960-4. PubMed ID: 2500431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasomal degradation of unassembled mutant type I collagen pro-alpha1(I) chains.
    Fitzgerald J; Lamandé SR; Bateman JF
    J Biol Chem; 1999 Sep; 274(39):27392-8. PubMed ID: 10488070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta.
    Chessler SD; Byers PH
    J Biol Chem; 1993 Aug; 268(24):18226-33. PubMed ID: 8349698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta.
    Chessler SD; Wallis GA; Byers PH
    J Biol Chem; 1993 Aug; 268(24):18218-25. PubMed ID: 8349697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta.
    Pace JM; Kuslich CD; Willing MC; Byers PH
    J Med Genet; 2001 Jul; 38(7):443-9. PubMed ID: 11432962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.
    Barnes AM; Ashok A; Makareeva EN; Brusel M; Cabral WA; Weis M; Moali C; Bettler E; Eyre DR; Cassella JP; Leikin S; Hulmes DJS; Kessler E; Marini JC
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2210-2223. PubMed ID: 31055083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in the carboxy-terminal propeptide of the Pro alpha 1(I) chain of type I collagen in a child with severe osteogenesis imperfecta (OI type III): possible implications for protein folding.
    Oliver JE; Thompson EM; Pope FM; Nicholls AC
    Hum Mutat; 1996; 7(4):318-26. PubMed ID: 8723681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular defect in an autosomal dominant form of osteogenesis imperfecta. Synthesis of type I procollagen containing cysteine in the triple-helical domain of pro-alpha 1(I) chains.
    de Vries WN; de Wet WJ
    J Biol Chem; 1986 Jul; 261(19):9056-64. PubMed ID: 3722186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrix.
    Cole WG; Chow CW; Bateman JF; Sillence DO
    J Med Genet; 1996 Nov; 33(11):965-7. PubMed ID: 8950680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones.
    Lamandé SR; Bateman JF
    Semin Cell Dev Biol; 1999 Oct; 10(5):455-64. PubMed ID: 10597628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoplasmic reticulum protein Hsp47 binds specifically to the N-terminal globular domain of the amino-propeptide of the procollagen I alpha 1 (I)-chain.
    Hu G; Gura T; Sabsay B; Sauk J; Dixit SN; Veis A
    J Cell Biochem; 1995 Nov; 59(3):350-67. PubMed ID: 8567753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.
    Pyott SM; Schwarze U; Christiansen HE; Pepin MG; Leistritz DF; Dineen R; Harris C; Burton BK; Angle B; Kim K; Sussman MD; Weis M; Eyre DR; Russell DW; McCarthy KJ; Steiner RD; Byers PH
    Hum Mol Genet; 2011 Apr; 20(8):1595-609. PubMed ID: 21282188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues.
    Cole WG; Campbell PE; Rogers JG; Bateman JF
    J Med Genet; 1990 Sep; 27(9):545-51. PubMed ID: 2121988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
    Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
    Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of cysteine for glycine within the carboxyl-terminal telopeptide of the alpha 1 chain of type I collagen produces mild osteogenesis imperfecta.
    Cohn DH; Apone S; Eyre DR; Starman BJ; Andreassen P; Charbonneau H; Nicholls AC; Pope FM; Byers PH
    J Biol Chem; 1988 Oct; 263(29):14605-7. PubMed ID: 3170557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of proteostasis defects caused by osteogenesis imperfecta mutations in the collagen-α2(I) C-propeptide domain.
    Doan ND; Hosseini AS; Bikovtseva AA; Huang MS; DiChiara AS; Papa LJ; Koller A; Shoulders MD
    J Biol Chem; 2020 Jul; 295(29):9959-9973. PubMed ID: 32482890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.
    Pace JM; Chitayat D; Atkinson M; Wilcox WR; Schwarze U; Byers PH
    J Med Genet; 2002 Jan; 39(1):23-9. PubMed ID: 11826020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
    Wenstrup RJ; Hunter AG; Byers PH
    Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 5' splice site mutation affecting the pre-mRNA splicing of two upstream exons in the collagen COL1A1 gene. Exon 8 skipping and altered definition of exon 7 generates truncated pro alpha 1(I) chains with a non-collagenous insertion destabilizing the triple helix.
    Bateman JF; Chan D; Moeller I; Hannagan M; Cole WG
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):729-35. PubMed ID: 7945197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.